Navigation Links
Watson Confirms Renvela® for Oral Suspension Patent Challenge
Date:7/12/2010

MORRISTOWN, N.J., July 12 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market sevelamer carbonate for oral suspension, 0.8g and 2.4g per packet.  Watson's sevelamer carbonate for oral suspension product is the generic version of Genzyme's Renvela® for Oral Suspension.  Renvela ® is a phosphate binder indicated for the control of serum phosphorus in patients with chronic kidney disease who are on dialysis.

Genzyme Corporation filed suit against Watson on July 9, 2010 in the United States District Court for the District of Maryland seeking to prevent Watson from commercializing its product prior to the expiration of U.S. Patent No. 5,667,775.  Genzyme's suit was filed under the provisions of the Hatch-Waxman Act, resulting in a stay of final FDA approval of Watson's ANDA for up to 30 months or until final resolution of the matter before the court, whichever occurs sooner, subject to any other exclusivities.  Based on available information, Watson believes it may be a first applicant to file an ANDA requesting approval of a generic version of Renvela®  for oral suspension, and, should its ANDA be approved, may be entitled to 180 days of generic market exclusivity for this dosage form.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc. is a leading global specialty pharmaceutical company.  The Company is engaged in the development, manufacturing, marketing and dist
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Watson to Host Conference Call and Webcast to Discuss Second Quarter 2010 Earnings
2. Watson Completes Acquisition of CRINONE® and PROCHIEVE® Product Line and Shares of Columbia Laboratories
3. Watsons Generic Prograf® 5 mg Receives FDA Approval
4. Watson Launches Generic Exelon®
5. Watson Confirms Columbia Laboratories Shareholder Approval of Proposed Acquisition of Progesterone-related Assets
6. Watson to Present at the Wells Fargo Securities 2010 Healthcare Conference
7. Watson Confirms Columbia Laboratories Filing of Definitive Proxy Relating to Watsons Acquisition of U.S. Rights to CRINONE® Progesterone Gel Product Line
8. Watsons Generic VALTREX® 500 mg and 1000 mg Receives FDA Approval
9. Watson Launches Generic Version of LIPITOR® in Canada
10. Watson to Present at the 2010 Citi Investment Research Global Healthcare Conference
11. Watson Reaches Settlement with Teva Over Seasonale(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2014)... , July 13, 2014 ... in Tokio veranstalteten ... firmenseitigen Bemühungen zur Neuausrichtung seines Forschungsrahmenprogramms. Die ... Überblick über die fortgeschrittenen klinischen Programme und ... Ziel der Tagung bestand darin, aktuelle Meldungen ...
(Date:7/13/2014)... 13, 2014  Eli Lilly and Company (NYSE: ... its non-clinical study in genetically engineered mice examining ... beta-amyloid antibody N3pG and beta-secretase inhibitor BACE (LY2811376). ... effective in removing clumps of amyloid-beta protein in ... to lead to Alzheimer,s disease (AD) – than ...
(Date:7/11/2014)... LOS ANGELES , July 11, 2014 /PRNewswire-iReach/ ... of e-liquid, a vegetable-glycol solution for use in ... one of the active ingredients in cannabis, cannabidiol ... in personal vaporizer devices, and other vaporizer technology. ... Cannabis naturally contains 483 different compounds ...
Breaking Medicine Technology:Astellas erörtert Pipeline-Fortschritte auf F&E-Tagung 2Astellas erörtert Pipeline-Fortschritte auf F&E-Tagung 3Astellas erörtert Pipeline-Fortschritte auf F&E-Tagung 4New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 2New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 3VAPETEK Releases CBD-Infused eLiquid For The Consumer Market 2
... Oct. 12 "The FDA,s just approved monthly drug treatment ... largest substance abuse treatment provider, CRC Health Group, Recovery Division ... country. Rhodes said the new treatment regimen "will provide addicts ... a new way to reduce or eliminate relapse. We are ...
... (NYSE: WPI ), a leading specialty pharmaceutical company, ... quarter 2010 financial results on Thursday, November 4, 2010 prior ... will also host a conference call and webcast at 8:30 ... its financial results and provide an update on the Company,s ...
Cached Medicine Technology:FDA's Just Approved Monthly Drug Treatment, Vivitrol Could Be 'Game Changer,' Says Country's Largest Drug Treatment Recovery President, CRC's Jerry Rhodes; Provides Addicts 'One Decision A Month Instead of 30' 2Watson to Host Conference Call and Webcast to Discuss Third Quarter 2010 Earnings 2
(Date:7/13/2014)... July 14, 2014 Worldwide ladies are ... selection. Angeldress.co.uk has taken a different approach and has ... items are offered in more colour choices that responded ... famous brand of women’s special occasion apparels. The company’s ... dress specialists are working hard to create the best ...
(Date:7/13/2014)... MillionaireCasket.com is a professional supplier of funeral ... caskets are selling well in the global market. Recently, the ... and launched a special offer for all the newly ... the company’s cherry caskets are made with superb materials. As ... people to show respect to the departed saint. MillionaireCasket.com is ...
(Date:7/13/2014)... An editorial published today in The Lancet ... into consideration the long term neurological problems that ... the most common form of sports-related traumatic brain ... concussions may include dementia, amyotrophic lateral sclerosis, and ... what is perhaps more concerning, is that even ...
(Date:7/13/2014)... the best treatment and variations in the quality of ... blood cancer patients still varies widely between regions within ... in European adults to date, published in The ... 5-year survival for most cancers of the blood has ... the approval of new targeted drugs in the early ...
(Date:7/13/2014)... Dallas, TX (PRWEB) July 13, 2014 ... Roma vs. Real Madrid Tickets . For the fifth ... International Champions Cup will be held at American stadiums this ... world competing on American soil. The eight teams are split ... the group stage, the top two teams will compete to ...
Breaking Medicine News(10 mins):Health News:Angeldress.co.uk Announces Summer Sale For Pink And Red Bridesmaid Dresses; The Current Discount Is Up To 80% Off 2Health News:Brand New Cherry Caskets Unveiled By China Casket Supplier MillionaireCasket.com 2Health News:The Lancet Oncology: Differences in treatment likely to be behind differing survival rates for blood cancers between regions within Europe 2Health News:The Lancet Oncology: Differences in treatment likely to be behind differing survival rates for blood cancers between regions within Europe 3Health News:AS Roma vs Real Madrid Tickets in Dallas at Cotton Bowl: Ticket Down Slashes Ticket Prices for Real Madrid vs AS Roma Guinness International Champions Cup Match 2Health News:AS Roma vs Real Madrid Tickets in Dallas at Cotton Bowl: Ticket Down Slashes Ticket Prices for Real Madrid vs AS Roma Guinness International Champions Cup Match 3
... disease has claimed a tenth of Idahos trout population and ... labor. , The outbreak of Ichthyophthirius multifilis has ... the state Department of Fish and Game hatchery, in Nampa. ... official say that it probably resulted when stress from overcrowding ...
... Dukhtaran-e-Milat (DeM) Monday opposed introduction of sex education in ... ,Addressing a media conference here, Asiya Andrabi, ... nail the nefarious Indian designs to perpetuate obscenity and ... education in schools." ,Andrabi, branded as a ...
... in regard to doctor-patient ratio in various State Government ... varies from case to case depending upon various factors ... of patient-care required i.e. indoor/outdoor. According to the Medical ... works out to 1:1722. ,The patient ...
... company Advanced Cell Technology, is obviously thrilled with ... repair arteries and regenerate blood. , According to ... proceed on to hearts and arteries of ... have devised a straightforward way to make blood vessel precursor ...
... the country are 73557. There are 22273 numbers of doctors ... areas as on March 2006. As on 1.1.2007, total numbers ... and 340308 beds are available in urban government hospitals including ... and 92.4% of CHCs are located in government buildings. As ...
... kala azar, a deadly parasitic disease transmitted by the tiny sand ... to battle the scourge. ,According to C.P. Thakur, a ... in Bihar, over 100,000 people, mostly the poor, are suffering from ... ,"They are dying in thousands and silently. It is unlike when ...
Cached Medicine News:Health News:Disease Outbreak Claims Trout From Idaho Hatchery 2Health News:Hemangioblasts Aiding Eye Damage Repair 2Health News:Bihar Under the Grip of Kala Azar 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: